Cipla exports $10 million worth of oseltamivir
This article was originally published in Scrip
Executive Summary
India's Cipla has exported oseltamivir, a cut-price generic version of Roche's Tamiflu, worth about $10 million to countries in Latin America, Africa, the Middle East and South East Asia.